Norwegian Cruise Line Holdings (NCLH) shares witnessed a substantial increase on Thursday, following the cruise operator's announcement of a significant rebound in bookings. The company reported that current booking volumes have now surpassed historical levels, signaling a robust recovery in the cruise industry.
The Miami-based firm, which manages Norwegian Cruise Line, Oceania Cruises, and Regent Seven Seas Cruises, disclosed its second-quarter financial results. The company reported adjusted earnings per share of $0.51, with revenue climbing 6% year-over-year to reach $2.52 billion. Although these figures were slightly below Visible Alpha's consensus estimates, the positive trends in bookings and onboard spending painted an optimistic picture.
Following the earnings release, NCLH's shares surged by 13%, pushing their value above $26. This upward movement positioned the stock in positive territory for the year, a significant turnaround given its dip to around $15 in early April, partly influenced by then-President Donald Trump's announcement of "Liberation Day" tariffs.
Harry Sommer, CEO of Norwegian, emphasized the widespread resurgence in demand across all three of the company's brands. He highlighted not only the accelerated booking pace but also the sustained strength in onboard expenditures. Sommer attributed this strong performance to the appeal of their diverse fleet offerings and a strategic focus on enhancing both investment returns and customer experiences.
The positive momentum in Norwegian's stock also had a ripple effect on its rivals. Shares of Carnival Corp. (CCL) and Royal Caribbean Group (RCL) saw increases of 1.5% and 1% respectively, indicating a general uplift across the cruise industry in response to renewed consumer confidence and demand for travel experiences.
A recent legislative enactment introduces specialized borrowing thresholds for various graduate programs. Presently, federal loan limits for graduate students do not differentiate based on their field of study. However, under the updated provisions, annual limits for unsubsidized loans will remain constant at $20,500 for general graduate programs, while professional students pursuing fields like medicine, dentistry, or law will see their annual borrowing capacity increase to $50,000.
Significant adjustments are also being made to the cumulative loan amounts students can incur throughout their graduate education. Currently, all graduate students face a uniform lifetime borrowing cap of $138,500. Beginning in July 2026, this will be recalibrated, with a new total limit of $100,000 for unsubsidized loans for general graduate students. Conversely, professional students will benefit from a higher overall limit of $200,000. It is also important to note that, for both graduate and professional students, the availability of PLUS loans and subsidized loans will be discontinued.
The new bill grants tertiary educational institutions the autonomy to impose reduced yearly loan maximums for both undergraduate and graduate students, tailored to specific fields of study. Furthermore, a comprehensive lifetime aggregate borrowing cap of $257,500 has been established, applicable across all levels of study, including undergraduate, graduate, and doctoral programs. For students enrolled on a less than full-time basis, defined as fewer than 24 credit hours, a revised calculation method will determine their borrowing eligibility. This new formula will directly link the amount a student can borrow to the number of credits they are pursuing. For instance, an undergraduate student enrolling for only 12 credit hours in an academic year will only be able to access half of their otherwise available loan amount. Additionally, annual limits for Parent PLUS loans, designed to assist parents with their child's educational expenses, will be capped at $20,000, with a new overall aggregate limit of $65,000. These limits represent a departure from previous policies, which allowed borrowing amounts to fluctuate based on institutional attendance costs and a child's financial aid package.
The Clorox Company has formally accused its long-term IT services partner, Cognizant Technology Solutions, of profound negligence and a serious breach of their contractual obligations. This accusation follows a damaging cyber incident that is estimated to have cost Clorox approximately $380 million in total, encompassing remediation expenses and significant business interruptions.
For more than a decade, Clorox entrusted Cognizant with the critical function of managing its employee service desk. This included sensitive operations such as password recovery and credential resets. A fundamental tenet of their agreement stipulated that no credentials would be reset without a stringent authentication process for the requesting party. However, Clorox contends that Cognizant repeatedly failed to adhere to these vital procedures, directly leading to the security compromise.
On August 11, 2023, a cybercriminal reportedly exploited these vulnerabilities. Clorox alleges that Cognizant's service desk granted the attacker direct access to Clorox's network credentials without any proper verification. Recorded conversations supposedly show a Cognizant agent explicitly providing a password to the cybercriminal without authentication. This critical lapse allowed unrestricted access to Clorox's systems, initiating a widespread attack.
The cyberattack had catastrophic consequences for Clorox. Its corporate network was severely crippled, supply chains were disrupted, and the company's ability to fulfill orders was significantly impaired. Beyond the initial impact, Clorox claims that Cognizant's subsequent incident response and disaster recovery efforts were mismanaged, exacerbating the overall damage. The total cost to Clorox included over $49 million in direct recovery expenses, alongside hundreds of millions in lost business due to operational paralysis.
In response to Clorox's claims, a Cognizant spokesperson issued a statement asserting that Clorox's internal cybersecurity system was inept and that Cognizant's role was limited to help desk services, which were, in their view, reasonably performed. Cognizant maintained that it was not responsible for Clorox's overall cybersecurity management. Despite the significant impact on Clorox, Cognizant reported robust revenues of $20 billion in 2024, seemingly unaffected by the controversy or associated reputational damage.